AQST vs. REAL
AQST (Aquestive Therapeutics, Inc.) and REAL (The RealReal, Inc.) are both stocks. AQST operates in Drug Manufacturers - Specialty & Generic (Healthcare), while REAL operates in Specialty Retail (Consumer Cyclical). Over the past 5 years, AQST returned -0.29%/yr vs -12.76%/yr for REAL. At a 0.26 correlation, their price movements are largely independent.
Performance
AQST vs. REAL - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with AQST having a -35.45% return and REAL slightly higher at -34.85%.
AQST
- 1D
- -0.95%
- 1M
- 0.97%
- YTD
- -35.45%
- 6M
- -32.85%
- 1Y
- 25.98%
- 3Y*
- 22.65%
- 5Y*
- -0.29%
- 10Y*
- —
REAL
- 1D
- 4.47%
- 1M
- 9.25%
- YTD
- -34.85%
- 6M
- -28.31%
- 1Y
- 92.87%
- 3Y*
- 81.13%
- 5Y*
- -12.76%
- 10Y*
- —
AQST vs. REAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | -35.45% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | 42.30% |
REAL The RealReal, Inc. | -34.85% | 44.37% | 443.78% | 60.80% | -89.23% | -40.58% | 3.66% | -32.68% |
Correlation
The correlation between AQST and REAL is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2019 | 0.26 |
Fundamentals
AQST:
$511.28M
REAL:
$3.23B
AQST:
-$0.61
REAL:
-$0.22
AQST:
9.42
REAL:
4.26
AQST:
$50.27M
REAL:
$722.53M
AQST:
$20.92M
REAL:
$529.97M
AQST:
-$53.08M
REAL:
-$60.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AQST vs. REAL — Risk / Return Rank
AQST
REAL
AQST vs. REAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aquestive Therapeutics, Inc. (AQST) and The RealReal, Inc. (REAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AQST | REAL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.90 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.25 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.43 | 1.80 | -1.37 |
| Martin ratioReturn relative to average drawdown | 0.81 | 3.95 | -3.13 |
Loading charts...
Drawdowns
AQST vs. REAL - Drawdown Comparison
The maximum AQST drawdown since its inception was -96.68%, roughly equal to the maximum REAL drawdown of -96.44%. Use the drawdown chart below to compare losses from any high point for AQST and REAL.
Loading charts...
Drawdown Indicators
| AQST | REAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.68% | -96.44% | -0.24% |
Max Drawdown (1Y)Largest decline over 1 year | -60.61% | -51.95% | -8.66% |
Max Drawdown (3Y)Largest decline over 3 years | -63.55% | -57.16% | -6.39% |
Max Drawdown (5Y)Largest decline over 5 years | -90.11% | -95.42% | +5.31% |
Current DrawdownCurrent decline from peak | -78.01% | -64.43% | -13.58% |
Average DrawdownAverage peak-to-trough decline | -76.92% | -67.33% | -9.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.01% | 23.62% | +8.39% |
Volatility
AQST vs. REAL - Volatility Comparison
Aquestive Therapeutics, Inc. (AQST) has a higher volatility of 21.51% compared to The RealReal, Inc. (REAL) at 17.24%. This indicates that AQST's price experiences larger fluctuations and is considered to be riskier than REAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AQST | REAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.51% | 17.24% | +4.27% |
Volatility (6M)Calculated over the trailing 6-month period | 68.41% | 48.58% | +19.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.07% | 77.43% | +7.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.62% | 97.37% | -14.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.69% | 93.85% | -6.16% |
Dividends
AQST vs. REAL - Dividend Comparison
Neither AQST nor REAL has paid dividends to shareholders.
Financials
AQST vs. REAL - Financials Comparison
This section allows you to compare key financial metrics between Aquestive Therapeutics, Inc. and The RealReal, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AQST vs. REAL - Profitability Comparison
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
REAL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The RealReal, Inc. reported a gross profit of 141.33M and revenue of 189.72M. Therefore, the gross margin over that period was 74.5%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
REAL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The RealReal, Inc. reported an operating income of -2.27M and revenue of 189.72M, resulting in an operating margin of -1.2%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
REAL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The RealReal, Inc. reported a net income of 38.94M and revenue of 189.72M, resulting in a net margin of 20.5%.
Frequently Asked Questions
AQST and REAL have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (21.51%) compared to REAL (17.24%). In terms of maximum drawdown, AQST dropped -96.68% vs REAL's -96.44%.
REAL currently has the higher Sharpe Ratio (1.21 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AQST and REAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer